Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease-Reference-Cited by-同舟云学术

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease

Published:2018-02-22 Issue: Volume: Page:annrheumdis-2017-212608
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Gabay Cem,Fautrel Bruno,Rech Jürgen,Spertini François,Feist Eugen,Kötter Ina,Hachulla Eric,Morel Jacques,Schaeverbeke Thierry,Hamidou Mohamed A,Martin Thierry,Hellmich Bernhard,Lamprecht Peter,Schulze-Koops Hendrik,Courvoisier Delphine Sophie,Sleight Andrew,Schiffrin Eduardo Jorge

Funder

AB2 Bio Ltd.

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference20 articles.

1. Adult-onset Still’s disease;Gerfaud-Valentin;Autoimmun Rev,2014

2. New markers for adult-onset Still’s disease;Mitrovic;Joint Bone Spine,2017

3. Juvenile chronic arthritis;Woo;Lancet,1998

4. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients;Gerfaud-Valentin;Medicine,2014

5. Pathogenesis and management of adult-onset Still’s disease;Efthimiou;Semin Arthritis Rheum,2006

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication;Reviews in the Neurosciences;2024-09-03

2. Insights into IL-1 family cytokines in kidney allograft transplantation: IL-18BP and free IL-18 as emerging biomarkers;Cytokine;2024-08

3. Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study;2024-07-03

4. The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome;Disease Models & Mechanisms;2024-07-01

5. An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation;Frontiers in Immunology;2024-06-25